Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet
2023-10-23 16:50
Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
You Might Like...
These Stocks Are Moving the Most Today: AMD, Paycom Software, First Solar, Match, WeWork, Yum China, and More
Cities: Skylines 2 Recommended Specs
Are Paige Spiranac and Trevor Lawrence related? Here's why golf influencer got offended by NFL player comparison
Baldur's Gate 3 Patch 2 Release Date
Will Madden 24 Have Crossplay? Here's What We Know so Far
Are xQc and Fran engaged? Fans speculate after ring from Twitch streamer’s Insta story spotted in rumored GF’s photo
Big X taken down from Twitter roof after San Francisco squabble
Apple is ending My Photo Stream in favor of iCloud Photos